Watts Water Options Shift Ahead of Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
WTS has pulled back 3.1% over the past week to $347.60, underperforming every one of its closest peers: GRC fell 2.5%, FELE dropped 3.0%, while GHM and TEX both gained ground. Among this peer group, WTS carries the most defensive options tilt heading into its November 4 result: the put/call ratio has climbed to 0.82, more than 1.75 standard deviations above its 20-day average of 0.39, and roughly double the level that held through most of October. Borrowing conditions tell a quieter story. Short interest amounts to just 2.8% of the free float, availability remains exceptionally loose, and the cost to borrow barely registers at 0.48%. There is no squeeze pressure, no crowded short to worry about.
The debate around WTS centres on whether the premium it commands can survive any disappointment in Q3. Analysts set targets averaging $404, about 16% above the current price, and the recent direction has been upward: Barclays lifted its target to $425 after Q2 results in August and upgraded to Overweight in June, while Keybanc raised its to $400. Against that optimism sits a stretched valuation, roughly 16.7x EV/EBITDA on current figures, with bears pointing to a roughly 22% premium to SMID-cap peers, exposure to softening European construction (about 30% of revenue), and the Horne family's near-68% voting grip limiting governance flexibility. The bull case rests on the datacenter franchise, where sales more than tripled year on year and now represent about 8% of year-to-date revenue, alongside raised full-year guidance and near-90% free-cash-flow conversion.
Retail attention has spiked sharply. ORTEX's Wikipedia pageview and platform traffic signal registered a z-score of 6.3 relative to the prior 90 days, its highest reading in recent months, suggesting a sudden uptick in individual investor interest around the print date. That is an attention measure, not a revenue indicator.
Timothy Horne, the controlling shareholder at 17.7% of shares, has held steady. BlackRock has added modestly, lifting its position to just over 10% as of September. On the insider ledger, the net 90-day flow runs negative: director Joseph Noonan sold roughly $1.3 million of shares across three open-market transactions in early September. The August grant activity from multiple directors carries no price signal, as these were compensation awards.
The Q3 report will test whether the datacenter growth story is durable enough at this valuation to absorb any softness in the legacy European and nonresidential segments that still account for the majority of revenue.
Stocks in this article
See the live data behind this article on ORTEX.
Open WTS on ORTEX →How this article was generated
- Generated
- 1 Nov 2026, 04:17
- Data as of
- 1 Nov 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.